Abstract:Plants and microbes commonly make terpenes and terpenoids in small amounts and as complex mixtures, and their chemical synthesis is often costly and inefficient. Hence, there are many efforts to create robust and efficient biological production platforms for this interesting class of molecules. In this study, our effort was directed towards building a yeast production platform using an unbiased genetic selection approach. Yeast strain BY4741 was subjected to EMS mutagenesis, followed by selection for growth in the presence of nystatin, squalestatin, and exogenous cholesterol. This unbiased screen selected for mutant yeast lines having a dispensable mevalonate pathway and containing uncharacterized SUE (sterol uptake enhancement) mutations supporting aerobic uptake of exogenous sterol. These mutants were next screened for high level accumulation of farnesol (FOH), an indicator for high level accumulation of the key intermediate FPP, farnesyl diphosphate. To further improve the FPP pool in these mutants, insertional mutations into the ERG9 gene (coding for squalene synthase) were introduced into those lines capable of accumulating ≥50 mg farnesol/L. This generated another series of lines that accumulated farnesol levels over 70 mg/L in small-scale shake cultures. To evaluate the utility of these lines as a general production platform for specific terpenes, select SUE/erg9 lines were transformed with a vector harboring the Hyoscyamus muticus premnaspirodiene synthase (HPS) gene encoding for a sesquiterpene synthase. The new yeast line ZX178-08 accumulated the highest level of premnaspirodiene, up to 116 mg/L, with FOH levels of 23.6 mg/L. In comparison, the parental line BY4741 accumulated 10 times less premnaspirodiene, 10.94 mg/L, with no farnesol detectable. Co-expression of the HPS gene with an amino-terminal truncated, catalytic form of the hamster HMGR gene, tHMGR, increased premnaspirodiene accumulation to 170.23 ± 30.44 mg/L, almost a 50% increase. Further utility of this yeast line was demonstrated for triterpene production. When engineered for the production of a non-native triterpene, Zx178-08 accumulated upwards of 60 mg/L of botryococcene. To engineer more native triterpene accumulation, additional insertion mutants into the ERG1 gene (coding for squalene epoxidase) were evaluated. Insertion of a simple selection marker followed by over-expression of a heterologous squalene synthase gene resulted in greater than 85 mg/L of squalene. However, when the ERG1 insertional mutant included chromosomal insertion of a truncated, heterologous HMGR gene, squalene production was more than tripled to 270 mg/L. These results are discussed in comparison to other recently developed terpene production platforms.

Engineering Critical Amino Acid Residues of Lanosterol Synthase to Improve the Production of Triterpenoids in Saccharomyces Cerevisiae

Boosting the epoxidation of squalene to produce triterpenoids in Saccharomyces cerevisiae

Engineering of Critical Enzymes and Pathways for Improved Triterpenoid Biosynthesis in Yeast

Construction of Lycopene-Overproducing Saccharomyces Cerevisiae by Combining Directed Evolution and Metabolic Engineering.

Combining Protein and Organelle Engineering for Linalool Overproduction in Saccharomyces Cerevisiae.

Reengineering the Substrate Tunnel to Enhance the Catalytic Efficiency of Squalene Epoxidase

Heterologous Biosynthesis of Taraxerol by Engineered Saccharomyces Cerevisiae

Combined Biosynthetic Pathway Engineering and Storage Pool Expansion for High-Level Production of Ergosterol in Industrial Saccharomyces cerevisiae

Rational design of lanosterol 14α-demethylase for ergosterol biosynthesis in Saccharomyces cerevisiae

Combinatorial Modulation of Linalool Synthase and Farnesyl Diphosphate Synthase for Linalool Overproduction in <i>Saccharomyces cerevisiae</i>

Building terpene production platforms in yeast

Biosynthesis of Squalene-Type Triterpenoids in Saccharomyces Cerevisiae by Expression of CYP505D13 from Ganoderma Lucidum

Engineering Saccharomyces cerevisiae for synthesis of β-myrcene and (E)-β-ocimene

Alpha-Terpineol Production from an Engineered Saccharomyces Cerevisiae Cell Factory

Engineering a universal and efficient platform for terpenoid synthesis in yeast

Improving the Production of Squalene-Type Triterpenoid 2,3;22,23-Squalene Dioxide by Optimizing the Expression of CYP505D13 in Saccharomyces Cerevisiae.

Tailoring the Saccharomyces cerevisiae endoplasmic reticulum for functional assembly of terpene synthesis pathway

Engineering of the Terpenoid Pathway in Saccharomyces Cerevisiae Co-Overproduces Squalene and the Non-Terpenoid Compound Oleic Acid

Enhancing Trans -Nerolidol Productivity in Yarrowia lipolytica by Improving Precursor Supply and Optimizing Nerolidol Synthase Activity.

Pathway engineering of Saccharomyces cerevisiae for efficient lycopene production

Enhancement of squalene synthesis in Candida tropicalis via combinatorial metabolic engineering strategies to rebuild pathways